Literature DB >> 24745685

Treatment strategies in mastocytosis.

Frank Siebenhaar1, Cem Akin2, Carsten Bindslev-Jensen3, Marcus Maurer4, Sigurd Broesby-Olsen3.   

Abstract

Treatment recommendations for mastocytosis are based mostly on expert opinion rather than evidence obtained from controlled clinical trials. In this article, treatment options for mastocytosis are presented, with a focus on the control of mediator-related symptoms in patients with indolent disease.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-IgE; Antihistamine; Antimediator therapy; Mastocytosis; Mediator-related symptoms; Platelet-activating factor

Mesh：

Substances：

Year:  2014        PMID： 24745685     DOI： 10.1016/j.iac.2014.01.012

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN： 0889-8561            Impact factor:   3.479


  11 in total

1.  Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

Authors:  Anastasia I Petra; Irene Tsilioni; Alexandra Taracanova; Alexandra Katsarou-Katsari; Theoharis C Theoharides
Journal:  Allergy Asthma Proc       Date:  2018-03-01       Impact factor: 2.587

2.  Role of Mast Cells in the Pathogenesis of Pruritus in Mastocytosis.

Authors:  Dominika Kwiatkowska; Adam Reich
Journal:  Acta Derm Venereol       Date:  2021-10-31       Impact factor: 3.875

Review 3.  Mast Cells in the Skin: Defenders of Integrity or Offenders in Inflammation?

Authors:  Martin Voss; Johanna Kotrba; Evelyn Gaffal; Konstantinos Katsoulis-Dimitriou; Anne Dudeck
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 4.  Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.

Authors:  David González-de-Olano; Almudena Matito; Alberto Orfao; Luis Escribano
Journal:  F1000Res       Date:  2016-11-14

5.  Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis.

Authors:  Noelia Dasilva-Freire; Andrea Mayado; Cristina Teodosio; María Jara-Acevedo; Iván Álvarez-Twose; Almudena Matito; Laura Sánchez-Muñoz; Carolina Caldas; Ana Henriques; Javier I Muñoz-González; Andrés C García-Montero; J Ignacio Sánchez-Gallego; Luis Escribano; Alberto Orfao
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

6.  Efficacy of Omalizumab in Indolent Systemic Mastocytosis.

Authors:  Calum Slapnicar; Martina Trinkaus; Lisa Hicks; Peter Vadas
Journal:  Case Rep Hematol       Date:  2019-09-16

Review 7.  Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis.

Authors:  Knut Brockow; Katarzyna Plata-Nazar; Magdalena Lange; Bogusław Nedoszytko; Marek Niedoszytko; Peter Valent
Journal:  Int J Mol Sci       Date:  2021-03-07       Impact factor: 5.923

Review 8.  Cutaneous mastocytosis in childhood.

Authors:  Katja Nemat; Susanne Abraham
Journal:  Allergol Select       Date:  2022-01-05

9.  Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients.

Authors:  Audrey Rouet; Achille Aouba; Gandhi Damaj; Erinn Soucié; Katia Hanssens; Marie-Olivia Chandesris; Cristina Bulai Livideanu; Marine Dutertre; Isabelle Durieu; Catherine Grandpeix-Guyodo; Stéphane Barète; Claude Bachmeyer; Angèle Soria; Laurent Frenzel; Olivier Fain; Bernard Grosbois; Christian de Gennes; Mohamed Hamidou; Jean-Benoit Arlet; David Launay; Christian Lavigne; Michel Arock; Olivier Lortholary; Patrice Dubreuil; Olivier Hermine; Sophie Georgin-Lavialle
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 10.  Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.

Authors:  Magdalena Lange; Karin Hartmann; Melody C Carter; Frank Siebenhaar; Ivan Alvarez-Twose; Inés Torrado; Knut Brockow; Joanna Renke; Ninela Irga-Jaworska; Katarzyna Plata-Nazar; Hanna Ługowska-Umer; Justyna Czarny; Anna Belloni Fortina; Francesca Caroppo; Roman J Nowicki; Bogusław Nedoszytko; Marek Niedoszytko; Peter Valent
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.